← Back to Clinical Trials
Recruiting NCT06967974

NCT06967974 Effects of Tai Chi on Chronic Insomnia Disorder Combined With Hyperarousal/Anxiety

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06967974
Status Recruiting
Phase
Sponsor Xuanwu Hospital, Beijing
Condition Chronic Insomnia
Study Type INTERVENTIONAL
Enrollment 80 participants
Start Date 2024-11-01
Primary Completion 2025-10-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Tai Chi + Sleep Hygiene EducationSleep Hygiene Education

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 80 participants in total. It began in 2024-11-01 with a primary completion date of 2025-10-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study focuses on individuals with chronic insomnia combined with excessive arousal/anxiety, with the main objective of investigating the effectiveness of Tai Chi in treating CI with excessive arousal/anxiety.

Eligibility Criteria

Inclusion Criteria: 1. meet DSM-5 diagnostic criteria for insomnia disorder; 2. Pittsburgh Sleep Quality Index (PSQI) total score \>5; 3. age ≥18 years old with junior high school education or above; 4. voluntarily participate in this study by signing an informed consent form; and 5) HAMA ≥14 was required for those who had chronic insomnia disorder with anxiety symptoms. Exclusion Criteria: 1. people with comorbid serious physical or severe mental illnesses, suicide risk; 2. clinically diagnosed or suspected sleep breathing disorder, restless legs syndrome and sleep-wake rhythm disorder, shift workers; 3. pregnant and breastfeeding women; and 4. people who are currently undergoing any psychological treatment.

Contact & Investigator

Central Contact

Hongxing Wang, MD & PhD

✉ wanghongxing@xwh.ccmu.edu.cn

📞 +86 13911127385

Frequently Asked Questions

Who can join the NCT06967974 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Chronic Insomnia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06967974 currently recruiting?

Yes, NCT06967974 is actively recruiting participants. Contact the research team at wanghongxing@xwh.ccmu.edu.cn for enrollment information.

Where is the NCT06967974 trial being conducted?

This trial is being conducted at Beijing, China.

Who is sponsoring the NCT06967974 clinical trial?

NCT06967974 is sponsored by Xuanwu Hospital, Beijing. The trial plans to enroll 80 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology